14 March 2018
The Ministry of Industry and Trade of Russia amended its Administrative Rules for licensing the manufacturing of medicinal products.
According to the Ministry, the relevant order was elaborated and approved to improve the quality of provision, period and availability of results of this public service provided by the Ministry, create comfortable conditions for participants in relations arising during the provision of service for licensing the manufacturing of medicinal products for human use, and defining the period and sequence of activities (administrative procedures).
In particular, the Rules were supplemented by clause 16.1, which stipulates that the Ministry of Industry and Trade may not:
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024